SK Pharmteco And Rznomics Explore RNA Gene Therapy Collaboration
05 Aug 2024 //
PR NEWSWIRE
Rznomics Inc. Secures Orphan Drug Designation from FDA for RZ-001
02 Feb 2024 //
PR NEWSWIRE
Rznomics Inc. Secures Fast Track Designation from the U.S. FDA for RZ-001
10 Nov 2023 //
PR NEWSWIRE
Charles River & Rznomics Announce Anticancer Gene Therapy Manufacturing Alliance
18 Jan 2023 //
BUSINESSWIRE